Search All News
Scientists have made rapid progress in customizing drugs for ultrarare diseases. The hard part now is making such treatments on a large scale.
The Carol and Gene Ludwig Center for Research on Neurodegeneration Will Bring Novel Approaches to Alzheimer’s and Other Neurodegenerative Disease Research
Communities of color are disproportionately impacted by chronic disease. "Columbia has a responsibility to improve the health and well-being of its neighbors," says Dr. Olajide Williams
A new study, lead by Dr. Jennifer J. Manly, shows that 1 in 10 Americans age 65 and over suffer from dementia, while 22% deal with mild cognitive impairment.
- March 20, 2023
A record-breaking number of physicians from Columbia Neurology were recognized as 2023 Castle Connolly Top Doctors!
- March 15, 2023
Hiral Shah, MD, assistant professor of neurology at CUIMC, talks about her work addressing the health disparities for Parkinson's disease diagnosis and treatment faced by minority communities.
- March 8, 2023
We celebrate the social, economic, political, and scientific achievements of women worldwide as well as those in our department and in our lives.
- February 27, 2023
Many people live years or even decades with dementia, which causes death. Researching the symptoms and causes can dramatically help dementia care and prevention.
- February 23, 2023
Health Matters spoke with Dr. James Noble, a neurologist at NewYork-Presbyterian/Columbia University Irving Medical Center who specializes in the treatment of dementia, to get the facts about FTD.
- February 19, 2023
As Davangere Devanand, a neurologist at CUIMC, combed through the reams of scientific data on Alzheimer’s, he stumbled across a surprising idea – could an infection be involved in driving the disease?